APA format, 2 pages, 3 references
Healthcare is an ever-evolving science. Research findings create changes that are communicated quickly through the Internet, paper publications, and eventually books. The MMSE has long been used to evaluate severity of Alzheimer’s disease. Research the Internet and find one other test that would be useful in screening or diagnosing Alzheimer’s disease. It must be a scientific test, not lay testing. Discuss why you would use this test in your practice as an advanced practice registered nurse or why not.
How to solve
week 10 Nurse practitioner Nursing Assignment Help
Introduction:
Healthcare remains an ever-evolving branch of science, continually improving and adapting to cater to numerous health conditions. With Alzheimer’s disease being a widespread problem globally, several tests can aid in screening and diagnosing the condition’s severity apart from the commonly used MMSE (Mini Mental State Examination) test. These tests undergo continuous research and validation globally, making it crucial for medical college students to remain updated with the latest developments. This paper discusses a scientific test useful in screening and diagnosing Alzheimer’s disease and the reasons for its use or omission in practice as an advanced practice registered nurse.
Test Useful in Screening and Diagnosing Alzheimer’s Disease:
One test useful in assessing cognitive decline and diagnosing Alzheimer’s disease is the Montreal Cognitive Assessment (MoCA). The MoCA assesses various cognitive domains, such as executive function, attention, memory, language, visuospatial skills, and orientation, using a 30-point scale. Several studies have shown that the MoCA is more sensitive to mild cognitive impairments than the MMSE test. Moreover, a study conducted by Nasreddine et al. (2005) reports that the MoCA’s cut-off scores had a sensitivity of 100% for detecting mild Alzheimer’s disease compared to the 79% sensitivity of the MMSE test.
Why Use or Omit the MoCA Test in Practice as an Advanced Practice Registered Nurse?
The MoCA has numerous benefits that make it crucial for use as an advanced practice registered nurse. Firstly, it can cater to a broader range of cognitive domains, assessing cognitive decline beyond memory, unlike the MMSE tests. Secondly, it has shown better sensitivity in detecting mild cognitive impairments and early Alzheimer’s disease. Thirdly, it is relatively brief, with an average time of 10-15 minutes during administration. In general, the MoCA test can aid in early detection and identification of Alzheimer’s disease, enhancing prompt intervention and improving the management of the condition in practice as an advanced practice registered nurse.
Despite these benefits, there might be reasons for omitting the MoCA test in practice as an advanced practice registered nurse. Firstly, the test requires specific training and certification to ensure accurate administration and interpretation. Secondly, variations in the administration of the test and the patient’s cultural and linguistic background can impact the validity of the results. Lastly, the test is relatively new and still undergoing research and validation in various populations, making it crucial to identify the target population and avoid applying it indiscriminately without scientific validation.
Conclusion:
The MoCA test presents an effective tool for screening and diagnosing Alzheimer’s disease with numerous benefits, including broad cognitive domain coverage, high sensitivity, and brevity. However, its application in practice as an advanced practice registered nurse requires adequate training and certification, identification of the target population, and validation in various populations. Ultimately, medical college students must remain updated with the latest test developments and their respective benefits and limitations to cater to patients’ needs and improve healthcare services.
References:
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., … Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699.
